[go: up one dir, main page]

HK1007103A1 - Natural pulmonary surfactant, method of preparation and pharmaceutical compositions - Google Patents

Natural pulmonary surfactant, method of preparation and pharmaceutical compositions Download PDF

Info

Publication number
HK1007103A1
HK1007103A1 HK98106244A HK98106244A HK1007103A1 HK 1007103 A1 HK1007103 A1 HK 1007103A1 HK 98106244 A HK98106244 A HK 98106244A HK 98106244 A HK98106244 A HK 98106244A HK 1007103 A1 HK1007103 A1 HK 1007103A1
Authority
HK
Hong Kong
Prior art keywords
surfactant
pulmonary surfactant
fraction
pulmonary
pharmaceutical compositions
Prior art date
Application number
HK98106244A
Other languages
German (de)
English (en)
Chinese (zh)
Other versions
HK1007103B (en
Inventor
Robertson Bengt
Curstedt Tore
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of HK1007103B publication Critical patent/HK1007103B/en
Publication of HK1007103A1 publication Critical patent/HK1007103A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)

Claims (8)

  1. Procédé de préparation d'un agent tensio-actif pulmonaire d'origine animale, formé d'une fraction lipidique polaire et d'une fraction protéique, dans lequel la fraction lipidique polaire est présente dans un pourcentage d'au moins 98,5% en poids et est à son tour principalement formée d'un mélange de phospholipides dans un pourcentage d'au moins 95%, sensiblement exempt de cholestérol et de glucides, caractérisé par le fait que :
    (a) à partir de poumons d'animaux triturés et lavés dans une solution saline, l'agent tensio-actif "in toto" est séparé, par des opérations de filtration, centrifugation et extraction subséquentes, avec un solvant organique ;
    (b) la fraction lipidique brute est récupérée par évaporation du solvant ;
    (c) le composant lipidique polaire, formé principalement de phospholipides, est finalement séparé du composant apolaire par chromatographie sur gel.
  2. Procédé selon la revendication 1, dans lequel la fraction phospholipidique est formée, pour au moins 70-75% en poids, de phosphatidylcholine, laquelle est, à son tour, formée d'au moins 40-45% en poids de dipalmitoyldiphosphatidylcholine.
  3. Procédé selon la revendication 1, dans lequel le composant protéique est formé exclusivement de protéines de faible masse moléculaire, comprise entre 3 et 14 K (K = kilodaltons).
  4. Procédé selon les revendications 1 à 3, caractérisé par le fait que la séparation de l'extrait lipidique brut est effectuée par chromatographie phase inverse sur une colonne LIPIDEX-5000®, avec un mélange dichloro-1,2 éthane/méthanol 1:4 (v/v).
HK98106244A 1987-04-08 1998-06-24 Natural pulmonary surfactant, method of preparation and pharmaceutical compositions HK1007103A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8720032A IT1203873B (it) 1987-04-08 1987-04-08 Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
IT2003287 1987-04-08

Publications (2)

Publication Number Publication Date
HK1007103B HK1007103B (en) 1999-04-01
HK1007103A1 true HK1007103A1 (en) 1999-04-01

Family

ID=11163272

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106244A HK1007103A1 (en) 1987-04-08 1998-06-24 Natural pulmonary surfactant, method of preparation and pharmaceutical compositions

Country Status (22)

Country Link
US (1) US5024995A (fr)
EP (1) EP0286011B1 (fr)
JP (1) JP2700323B2 (fr)
AT (1) ATE99949T1 (fr)
AU (1) AU619462B2 (fr)
CA (1) CA1320440C (fr)
DE (2) DE286011T1 (fr)
DK (1) DK172921B1 (fr)
EG (1) EG19626A (fr)
ES (1) ES2004856T3 (fr)
FI (1) FI92905C (fr)
GR (1) GR890300026T1 (fr)
HK (1) HK1007103A1 (fr)
HU (1) HU211950A9 (fr)
IE (1) IE61384B1 (fr)
IT (1) IT1203873B (fr)
MY (1) MY103260A (fr)
NO (1) NO174733C (fr)
NZ (1) NZ224146A (fr)
PH (1) PH25300A (fr)
PT (1) PT87188B (fr)
ZA (1) ZA882416B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
CA2083171C (fr) * 1990-05-18 2002-09-10 Kurashima Kazuyoshi Antasthmatique
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
EP0583358B1 (fr) * 1991-05-03 1998-12-02 Alliance Pharmaceutical Corporation Respiration liquide partielle des fluorocarbones
JPH07503629A (ja) * 1991-11-14 1995-04-20 アライアンス　ファーマシューティカル　コーポレイション フルオロカーボンを用いた部分的液体呼吸法および装置
IT1255967B (it) * 1992-11-27 1995-11-17 Chiesi Farma Spa Procedimento per la purificazione di materiale surfattante polmonare naturale con l'impiego di fluidi supercritici
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
BR9506114A (pt) * 1994-12-29 1997-12-23 Ctro Nac Sanidad Agropecuaria Tensoativo pulmonar de origem suína e processo para a sua obtenção
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
WO1997029738A1 (fr) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Procedes et compositions de traitement par inhalation du dysfonctionnement de la trompe d'eustache
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
EP1435994B1 (fr) 2001-10-11 2010-05-19 Nycomed GmbH Nouvelle utilisation de surfactant pulmonaire
RU2198670C1 (ru) * 2002-02-19 2003-02-20 ООО "Биосурф" Способ получения сурфактанта из легких крупного рогатого скота
ATE457736T1 (de) 2004-08-06 2010-03-15 Nycomed Gmbh Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
SI1841458T1 (sl) 2005-01-06 2012-04-30 Discovery Lab Inc Zdravljenje s predpisanim odmerjanjem surfaktanta za zdravljenje ali preprečevanje bronhopulmonalne displazije
GB2426703B (en) * 2005-05-31 2007-09-19 Malvern Cosmeceutics Ltd Compositions
EP2063903A1 (fr) * 2006-09-19 2009-06-03 Discovery Laboratories, Inc. Formulations de surfactant pulmonaire et procédés favorisant l'élimination du mucus
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
DE102007025898A1 (de) * 2007-06-01 2008-12-04 Matthias W. Dr. Amrein Behandlung von Surfactanten
WO2010068754A2 (fr) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Procédés et compositions pour la délivrance de médicaments aux poumons
JP2020526585A (ja) * 2017-07-07 2020-08-31 リポバイオメド コーポレイションＬｉｐｏｂｉｏｍｅｄ Ｃｏｒｐｏｒａｔｉｏｎ 火傷及び褥瘡の緩和及び治療用組成物
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants
WO2023280737A1 (fr) 2021-07-05 2023-01-12 Chiesi Farmaceutici S.P.A. Procédé de préparation d'un tensioactif pulmonaire

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
JPS58222022A (ja) * 1982-06-21 1983-12-23 Teijin Ltd 合成肺表面活性剤及びそれを有効成分とする呼吸窮迫症候群治療剤
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
BG49073A1 (en) * 1983-12-08 1991-08-15 Dresden Arzneimittel Remedy for treatment of asthmatic syndrome caused by lack of surface- active substance and method for obtaining it
JPS6165821A (ja) * 1984-09-07 1986-04-04 Tokyo Tanabe Co Ltd 合成サ−フアクタント及びそれを有効成分とする肺表面活性物質喪失性無気肺の治療剤
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
JPS63503222A (ja) * 1986-05-06 1988-11-24 サイオス　ノバ　インコーポレイテッド 肺の疎水性界面活性物質に結合した分子量６，０００ダルトンのタンパク質及びその多量体

Also Published As

Publication number Publication date
NO881515L (no) 1988-10-10
ATE99949T1 (de) 1994-01-15
NO881515D0 (no) 1988-04-07
DK190088D0 (da) 1988-04-07
NO174733B (no) 1994-03-21
DE3886970D1 (de) 1994-02-24
FI881508L (fi) 1988-10-09
DE286011T1 (de) 1989-03-09
ZA882416B (en) 1988-09-28
EP0286011A3 (en) 1990-02-07
NZ224146A (en) 1991-06-25
NO174733C (no) 1994-06-29
IE881008L (en) 1988-10-08
EP0286011A2 (fr) 1988-10-12
AU619462B2 (en) 1992-01-30
IE61384B1 (en) 1994-11-02
IT8720032A0 (it) 1987-04-08
US5024995A (en) 1991-06-18
PT87188A (pt) 1988-05-01
FI881508A0 (fi) 1988-03-30
FI92905C (fi) 1995-01-25
IT1203873B (it) 1989-02-23
MY103260A (en) 1993-05-29
GR890300026T1 (en) 1989-04-12
DK190088A (da) 1988-10-09
FI92905B (fi) 1994-10-14
JP2700323B2 (ja) 1998-01-21
PH25300A (en) 1991-04-30
DK172921B1 (da) 1999-10-04
DE3886970T2 (de) 1994-05-26
HU211950A9 (en) 1996-01-29
PT87188B (pt) 1992-07-31
AU1433788A (en) 1988-10-13
EG19626A (en) 1995-09-30
CA1320440C (fr) 1993-07-20
ES2004856A4 (es) 1989-02-16
ES2004856T3 (es) 1994-12-16
JPS6463526A (en) 1989-03-09
EP0286011B1 (fr) 1994-01-12

Similar Documents

Publication Publication Date Title
EP0286011B1 (fr) Surfactif pulmonaire naturel, procédé de préparation et compositions pharmaceutiques
HK1007103B (en) Natural pulmonary surfactant, method of preparation and pharmaceutical compositions
EP1005485B1 (fr) Utilisations therapeutiques des tensioactifs diluee pour le lavage pulmonaire
GB2050832A (en) Surface active material containing phospholipid lipid carbohydrate and protein
RU2041717C1 (ru) Биологически активное средство, способ его получения и препарат, содержащий указанное средство, и способ использования препарата
EP0652011A1 (fr) Agent prophylactique et agent curatif contre des maladies virales des voies respiratoires
US6180142B1 (en) Reduction of surfactant inactivation in pulmonary surfactant therapy
CZ162396A3 (en) Synthetic peptides, process of their preparation and pharmaceutical composition containing thereof
EP0145005B1 (fr) Tensio-actif pulmonaire, procédé de préparation et utilisation pharmaceutique
DE69928279T2 (de) Lungensurfactant zubereitungen enthaltendes behandlungset
RU2041715C1 (ru) Биологически активное средство, способ его получения, препарат, содержащий указанное средство, и способ использования препарата
JP3376582B2 (ja) 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤
KR960013436B1 (ko) 천연 폐 계면활성제, 그의 제조방법 및 이것을 함유하는 제약 조성물
RU2066197C1 (ru) Способ получения легочного сурфактанта
RU2198670C1 (ru) Способ получения сурфактанта из легких крупного рогатого скота
PL211789B1 (pl) Kompozycje zawierające hemoglobinę płodową i endotoksynę bakteryjną oraz opcjonalnie, dodatkowe składniki wątroby płodowej
RU2066198C1 (ru) Способ получения легочного сурфактанта
CN116987181B (zh) 高生物学活性的天然水蛭素和高收率制备它们的方法
KR101721309B1 (ko) 계면활성 단백질 ｂ(ｓｐ－ｂ) 및 계면활성 단백질 ｃ(ｓｐ－ｃ)의 유사체를 포함하는 합성 폐 계면활성제 조성물
BG99445A (bg) Биологично активно средство с имуномодулиращо свойство, метод за получаването му и лекарствен препарат на неговата основа
JPS60237023A (ja) 界面活性剤欠乏起因の呼吸困難症候群を治療するための薬剤およびその製造法
JPH08169845A (ja) ヒト由来アンチトロンビン−ｉｉｉの新規用途
LT4102B (en) Biologically active immunomodulating material, process for preparing thereof, pharmaceutical preparation for the human and animals physiological state conditioning
JPS6361000A (ja) リポ蛋白質及びその製造法

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080330